Tenaya Therapeutics to Participate in Upcoming Investor and Industry Conferences
September 30 2021 - 6:02PM
Business Wire
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology
company with a mission to discover, develop and deliver curative
therapies that address the underlying causes of heart disease,
announced today that Faraz Ali, Chief Executive Officer, is
scheduled to participate in the Chardan 5th Annual Genetic
Medicines Conference, the Alliance for Regenerative Medicine’s Cell
and Gene Meeting on the Mesa and the Jefferies Gene Therapy/Editing
Summit in October. Details of the presentations are as follows:
Chardan 5th Annual Genetic Medicines Conference Panel:
Genetic Medicines: The Ongoing Emergence of the Heart as a Target
Tissue Date: Monday, October 4, 2021 Time: 3:00 p.m. ET
Fireside Chat Date: Monday, October 4, 2021 Time: 4:00 p.m.
ET
Alliance for Regenerative Medicine’s Cell and Gene Meeting on
the Mesa Panel: Personalizing Cardiovascular Therapies To
Address The Underlying Causes Of Disease Date: Wednesday, October
13, 2021 Time: 3:15 p.m. PT
Company Presentation Date: Wednesday, October 13, 2021 Time:
4:45 p.m. PT
Jefferies Gene Therapy/Editing Summit Company
Presentation Date: Thursday, October 28, 2021 Time: 11:30 a.m
ET
About Tenaya Therapeutics
Tenaya Therapeutics is a biotechnology company committed to a
bold mission: to discover, develop and deliver curative therapies
that address the underlying drivers of heart disease. Founded by
leading cardiovascular scientists from Gladstone Institutes and the
University of Texas Southwestern Medical Center, Tenaya is
developing therapies for rare genetic disorders as well as for more
prevalent heart conditions through three distinct but interrelated
product platforms: Gene Therapy, Cellular Regeneration and
Precision Medicine. For more information, visit
www.tenayatherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210930006008/en/
For more information: Investor Contact Leone
Patterson Tenaya Therapeutics IR@tenayathera.com
Media Contact: Wendy Ryan Ten Bridge Communications
wendy@tenbridgecommunications.com
Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
From Sep 2023 to Sep 2024